Expression of SORL1 and a novel SORL1 splice variant in normal and Alzheimers disease brain

Molecular Neurodegeneration

Volumn 4, Issue 1, 2009, Pages

  Grear, Karrie E ^a   Ling, I Fang ^a   Simpson, James F ^a   Furman, Jennifer L ^a   Simmons, Christopher R ^a   Peterson, Shawn L ^a   Schmitt, Frederick A ^a   Markesbery, William R ^a   Liu, Qiang ^b   Crook, Julia E ^c   Younkin, Steven G ^d   Bu, Guojun ^b   Estus, Steven ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MAYO CLINIC   (United States)

^d MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISOPROTEIN; MEMBRANE PROTEIN; RNA; SORTILIN RELATED RECEPTOR 1; SYNAPTOPHYSIN; UNCLASSIFIED DRUG;

AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; EXON; GENE EXPRESSION; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; INTRON; LINEAR REGRESSION ANALYSIS; NEUROPATHOLOGY; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ASSAY; REAL TIME POLYMERASE CHAIN REACTION; RNA SPLICING; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; WHITE MATTER;

EID: 72849132718     PISSN: None     EISSN: 17501326     Source Type: Journal    
DOI: 10.1186/1750-1326-4-46     Document Type: Article

References (25)

1. Activation and functional characterization of the mosaic receptor SorLA/LR11. L Jacobsen P Madsen C Jacobsen MS Nielsen J Gliemann CM Petersen, J Biol Chem 2001 276 22788 96 10.1074/jbc.M100857200 11294867
2. Neuronal sorting protein-related receptor sorLA/LR11 regulates processing of the amyloid precursor protein. OM Andersen J Reiche V Schmidt M Gotthardt R Spoelgen J Behlke CA von Arnim T Breiderhoff P Jansen X Wu KR Bales R Cappai CL Masters J Gliemann EJ Mufson BT Hyman SM Paul A Nykjaer TE Willnow, Proc Natl Acad Sci USA 2005 102 13461 6 16174740 10.1073/pnas.0503689102 (Pubitemid 41420870)
3. The lipoprotein receptor LR11 regulates amyloid beta production and amyloid precursor protein traffic in endosomal compartments. K Offe SE Dodson JT Shoemaker JJ Fritz M Gearing AI Levey JJ Lah, J Neurosci 2006 26 1596 603 16452683 10.1523/JNEUROSCI.4946-05.2006 (Pubitemid 43237030)
4. Loss of LR11/sorLA enhances early pathology in a mouse model of amyloidosis: Evidence for a proximal role in Alzheimer's disease. SE Dodson OM Andersen V Karmali JJ Fritz D Cheng J Peng AI Levey TE Willnow JJ Lah, J Neurosci 2008 28 12877 86 19036982 10.1523/JNEUROSCI.4582-08.2008
5. Loss of apolipoprotein E receptor LR11 in Alzheimer disease. CR Scherzer K Offe M Gearing HD Rees G Fang CJ Heilman C Schaller H Bujo AI Levey JJ Lah, Arch Neurol 2004 61 1200 5 10.1001/archneur.61.8.1200 15313836
6. Neuronal LR11/sorLA expression is reduced in mild cognitive impairment. KL Sager J Wuu SE Leurgans HD Rees M Gearing EJ Mufson AI Levey JJ Lah, Ann Neurol 2007 62 640 7 17721864 10.1002/ana.21190
7. Lr11/sorLA expression is reduced in sporadic Alzheimer disease but not in familial Alzheimer disease. SE Dodson M Gearing CF Lippa TJ Montine AI Levey JJ Lah, J Neuropathol Exp Neurol 2006 65 866 72 16957580 10.1097/01.jnen. 0000228205.19915.20 (Pubitemid 44371232)
8. The neuronal sortilin-related receptor Sorl1 is genetically associated with Alzheimer disease. E Rogaeva Y Meng JH Lee Y Gu T Kawarai F Zou T Katayama CT Baldwin R Cheng H Hasegawa F Chen N Shibata KL Lunetta R Pardossi-Piquard C Bohm Y Wakutani LA Cupples KT Cuenco RC Green L Pinessi I Rainero S Sorbi A Bruni R Duara RP Friedland R Inzelberg W Hampe H Bujo YQ Song OM Andersen TE Willnow N Graff-Radford RC Petersen D Dickson SD Der PE Fraser G Schmitt-Ulms S Younkin R Mayeux LA Farrer P St George-Hyslop, Nat Genet 2007 39 168 77 17220890 10.1038/ng1943 (Pubitemid 46184347)
9. Association between genetic variants in sortilin-related receptor 1 (Sorl1) and Alzheimer's disease in adults with Down syndrome. JH Lee M Chulikavit D Pang WB Zigman W Silverman N Schupf, Neurosci Lett 2007 425 105 9 17826910 10.1016/j.neulet.2007.08.042 (Pubitemid 47410369)
10. Sorl1 variants and risk of late-onset Alzheimer's disease. Y Li C Rowland J Catanese J Morris S Lovestone MC O'Donovan A Goate M Owen J Williams A Grupe, Neurobiol Dis 2008 29 293 6 17949987 10.1016/j.nbd.2007.09.001
11. No association of Sorl1 SNPs with Alzheimer's disease. RL Minster ST DeKosky MI Kamboh, Neurosci Lett 2008 440 190 2 18562096 10.1016/j.neulet.2008. 05.082
12. Association between genetic variants in Sorl1 and autopsy-confirmed Alzheimer disease. JH Lee R Cheng LS Honig JP Vonsattel L Clark R Mayeux, Neurology 2008 70 887 9 17978276 10.1212/01.wnl.0000280581.39755.89
13. Association between Sorl1 and Alzheimer's disease in a genome-wide study. Y Meng JH Lee R Cheng P St George-Hyslop R Mayeux LA Farrer, Neuroreport 2007 18 1761 4 18090307 10.1097/WNR.0b013e3282f13e7a (Pubitemid 350303747)
14. Sorl1 haplotypes modulate risk of Alzheimer's disease in Chinese. EK Tan J Lee CP Chen YY Teo Y Zhao WL Lee, Neurobiol Aging 2009 30 7 1048 51 10.1016/j.neurobiolaging.2007.10.013 18063222
15. Splicing in disease: Disruption of the splicing code and the decoding machinery. GS Wang TA Cooper, Nat Rev Genet 2007 8 749 61 10.1038/nrg2164 17726481
16. Alternative splicing in disease. JP Orengo TA Cooper, Adv Exp Med Biol 2007 623 212 23 18380349
17. Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute working group on diagnostic criteria for the neuropathological assessment of Alzheimer's disease. Neurobiol Aging 1997 18 1 2 10.1016/S0197-4580(97)00057-2 9330978
18. Neuropathology and cognitive impairment in Alzheimer disease: A complex but coherent relationship. PT Nelson H Braak WR Markesbery, J Neuropathol Exp Neurol 2009 68 1 14 19104448 10.1097/NEN.0b013e3181919a48
19. Single-step method of RNA isolation by acid guanidinium thiocynate-phenol-chloroform extraction. P Chomczynski N Sacchi, Anal Biochem 1987 162 156 159 10.1016/0003-2697(87)90021-2 2440339
20. The expression of several mitochondrial and nuclear genes encoding the subunits of electron transport chain enzyme complexes, cytochrome c oxidase, and NADH dehydrogenase, in different brain regions in Alzheimer's disease. MY Aksenov HM Tucker P Nair MV Aksenova DA Butterfield S Estus WR Markesbery, Neurochem Res 1999 24 767 774 10.1023/A:1020783614031 10447460
21. A common polymorphism decreases low-density lipoprotein receptor exon 12 splicing efficiency and associates with increased cholesterol. H Zhu HM Tucker KE Grear JF Simpson AK Manning LA Cupples S Estus, Hum Mol Genet 2007 16 1765 72 17517690 10.1093/hmg/ddm124 (Pubitemid 47241835)
22. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. J Vandesompele K De Preter F Pattyn B Poppe N Van Roy A De Paepe F Speleman, Genome Biol 2002 3 34.1 34.11 10.1186/gb-2002-3-7-research0034
23. "Preclinical" AD revisited: Neuropathology of cognitively normal older adults. FA Schmitt DG Davis DR Wekstein CD Smith JW Ashford WR Markesbery, Neurology 2000 55 370 6 10932270
24. Neuropathology of nondemented aging: Presumptive evidence for preclinical Alzheimer disease. JL Price DW McKeel Jr VD Buckles CM Roe C Xiong M Grundman LA Hansen RC Petersen JE Parisi DW Dickson CD Smith DG Davis FA Schmitt WR Markesbery J Kaye R Kurlan C Hulette BF Kurland R Higdon W Kukull JC Morris, Neurobiol Aging 2009 30 1026 36 10.1016/j.neurobiolaging.2009.04.002 19376612
25. Systematic meta-analyses of Alzheimer disease genetic association studies: The Alzgene database. L Bertram MB McQueen K Mullin D Blacker RE Tanzi, Nat Genet 2007 39 17 23 10.1038/ng1934 17192785